Inc_FF100_SocialToolkit_2024_1200x675
Lily AI’s Co-Founders Purva Gupta and Sowmiya Chocka Narayanan Make Inc.’s 2024 Female Founders List
April 09, 2024 09:15 ET | Lily AI
Lily AI’s Co-Founders Purva Gupta and Sowmiya Chocka Narayanan Make Inc.’s 2024 Female Founders List.
logo-vsa-portrait-white-rgb.jpg
With Extensive Two-Year Revenue Growth, ValueSelling Associates is Selected to Inc. Magazine’s List of the Pacific Region’s Fastest-Growing Private Companies
February 28, 2024 13:09 ET | ValueSelling Associates, Inc.
ValueSelling Associates has been selected to the Inc. 5000 Regionals Pacific list, showcasing the fastest-growing Pacific private companies.
Aclaris_Logo_CLR®.jpg
Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
February 27, 2024 07:00 ET | Aclaris Therapeutics, Inc.
WAYNE, Pa., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for...
Aclaris_Logo_CLR®.jpg
Aclaris Therapeutics Announces Leadership Changes and Strategic Business Review
January 16, 2024 07:00 ET | Aclaris Therapeutics, Inc.
- Douglas Manion, M.D. to step down as Chief Executive Officer, President and Member of Board of Directors - - Dr. Neal Walker, Current Chairman and Co-founder, Appointed as Interim Chief Executive...
Aclaris_Logo_CLR®.jpg
Aclaris Therapeutics Announces Top-line Results from 4-Week Phase 2b Trial of ATI-1777 for Mild to Severe Atopic Dermatitis
January 10, 2024 07:00 ET | Aclaris Therapeutics, Inc.
- ATI-1777 2% BID Achieved a Statistically Significant Result in the Primary Efficacy Endpoint at Week 4 - - Minimal Systemic Exposure Supports “Soft” Topical JAK Inhibitor Approach - - ATI-1777...
Fundable for Life, Inc. Partners with The Latino Franchise Association to Provide its Clients TV and Digital Print Media Along with Funding Options
December 21, 2023 08:00 ET | Fundable for Life, Inc.
Fundable for Life, Inc. provides business owners channels for media exposure and funding options so they can grow their businesses.
Aclaris_Logo_CLR®.jpg
Aclaris Therapeutics Provides Corporate Update
December 19, 2023 16:01 ET | Aclaris Therapeutics, Inc.
- ATI-1777 Phase 2a Trial Results Published in JID Innovations -- ATI-1777 Phase 2b Trial Topline Data Anticipated in January 2024 -- Aclaris Announces Reduction in Workforce - WAYNE, Pa., Dec. 19,...
Fundable for Life, Inc. Partners with Boston BioLife to Provide its Members TV and Digital Print Media Along with Funding Options
December 18, 2023 08:00 ET | Fundable for Life, Inc.
Fundable for Life, Inc. provides business owners channels for media exposure and funding options so they can grow their businesses.
tryc_app_icon_167x167.png
Fundable for Life, Inc. Partners with FMS Franchise to Provide its Clients TV and Digital Print Media Along with Funding Options
December 13, 2023 08:00 ET | Fundable for Life, Inc.
Fundable for Life, Inc. provides business owners channels for media exposure and funding options so they can grow their businesses.
tryc_app_icon_1024x1024.png
Fundable for Life, Inc. Partners with Top Doctor Magazine to Provide its Members TV and Print Media Along with Funding Options
December 11, 2023 13:05 ET | Fundable for Life, Inc.
Fundable for Life, Inc. provides business owners channels for media exposure and funding options so they can grow their businesses.